RecruitingOBSERVATIONAL

Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology

This study is investigating fertility preservation methods for women aged 18-47 who have recovered from cancer or certain blood disorders. Many cancer treatments can affect a woman's ability to have children, so fertility preservation is often offered beforehand. However, we don't fully understand the long-term success of these treatments, how often women use their preserved fertility, or the emotional impact. This research aims to understand these aspects better, following women over time to see what happens and how they feel. The goal is to improve the support and care offered to women in similar situations, ensuring they receive the best possible advice and treatment.

At a glance

Status

Recruiting

Sponsor

Centre Hospitalier Universitaire, Amiens

Enrolment target

102

Start

17 Dec 2025

Estimated completion

01 Jan 2027

Fertility Preservation Cancer Remission Reproductive Outcomes Reproductive Health Oncology Fertility Counseling Assisted Reproductive Technology Psychological Impact Fertility Observatory Patient Follow-up Female Cancer Survivors Fertility Preservation Techniques Live Birth Rate

What is this study about?

When women of childbearing age are diagnosed with cancer or certain blood conditions, the treatments can sometimes make it harder to have children later. To help with this, doctors often discuss options to protect their fertility before treatment starts. This process is called fertility preservation. While these options are becoming more common, we still have a lot to learn about what happens in the long run.

This important study aims to understand how effective these fertility preservation methods truly are. It will look at how many women successfully have children after using these methods, how many decide to use their preserved eggs or embryos, and how many choose not to. The study also wants to understand the emotional journey of women who go through this, as dealing with cancer and fertility concerns can be very challenging.

By carefully following women who have been treated at Amiens-Picardie University Hospital, researchers hope to gather vital information. This will help them identify ways to improve the advice, support, and medical care given to women who need to protect their fertility before cancer treatment. The overall goal is to make sure women receive the best possible care and support for their future family planning.

Key takeaways

This study looks at long-term results of fertility preservation for cancer survivors.
It aims to understand how these methods are used and their emotional impact.
The research helps doctors improve support for future patients.
It's for women aged 18-47 who are in remission from cancer or blood disorders.
Participation helps us learn more about women's journeys after cancer treatment.

Who may be eligible?

This study is looking for women who meet specific criteria. You might be able to take part if you are a woman between 18 and 47 years old.

You would also need to have been diagnosed with cancer or a blood problem that required treatment that could affect your ability to have children. Crucially, you must have already had a doctor's visit to discuss fertility preservation before your treatment began. You should also be receiving follow-up care at Amiens-Picardie University Hospital and currently be in remission (meaning your cancer or blood condition is under control).

However, you cannot take part if your cancer or blood condition is not in remission. Also, if you are legally unable to make your own decisions (for example, under guardianship), or if you simply don't want to participate, you would not be included.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you a woman between 18 and 47 years old?
Have you had cancer or a significant blood disorder?
Did you discuss fertility preservation with your doctor before your treatment?
Are you currently in remission from your condition?
Do you receive your medical follow-up at Amiens-Picardie University Hospital?

Answer every question to see your result.

What does participation involve?

The information provided does not detail the specific steps involved in taking part in this study. However, generally, participation in studies like this might involve:

* **Providing access to your medical records:** This would allow researchers to look at your past treatments, fertility preservation methods, and reproductive outcomes. * **Completing questionnaires:** These might ask about your experiences, decisions regarding fertility preservation, and your emotional well-being over time. * **Interviews:** You might be asked to participate in discussions about your journey and choices. * **Follow-up over a period of time:** This study focuses on "long-term evaluation," so it's likely that researchers would collect information from you at different points over several years.

The study aims to understand past experiences and outcomes, so it's less likely to involve new medical treatments or procedures. The total duration of your involvement isn't specified, but it's focused on long-term follow-up.

Potential risks and benefits

Participating in this study might not offer direct medical benefits to you personally, as it mainly involves looking back at past experiences and outcomes. However, the information you share will be incredibly valuable. It will help doctors and healthcare providers better understand fertility preservation and improve the care for other women facing similar situations in the future. The main risks are likely linked to giving your time and potentially discussing sensitive personal information, which some might find emotionally challenging. You are always free to change your mind and stop participating in the study at any time without it affecting your medical care.

Locations (1)

CHU Amiens Picardie
Verified postcode
Amiens, France· Recruiting

Common questions

What is 'fertility preservation'?

It's about taking steps, like freezing eggs or embryos, before cancer treatment to try and keep the option of having children open for the future.

Who is this study for?

It's for women aged 18-47 who have recovered from cancer or certain blood disorders and had fertility preservation discussions before their treatment.

What will the study actually do?

It will look at how well fertility preservation worked for these women, how they used their options, and the emotional impact over time, to improve future care.

Could this study help me directly?

It won't offer new treatments, but your information will help improve care and support for other women in the future who need fertility preservation.

Is my information kept private?

Yes, all studies have strict rules to protect your personal information and ensure it's kept confidential.

How to find out more

CABRY-GOUBET Rosalie, Pr

cabry.rosalie@chu-amiens.fr 33+3 22 08 80 00 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.